Cargando…

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis

An unintended consequence of newborn screening for cystic fibrosis (CF) is the identification of infants with a positive screening test but an inconclusive diagnostic testing. These infants are designated as CF transmembrane conductance regulator-related metabolic syndrome (CRMS) in the US and CF sc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Munck, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422971/ https://www.ncbi.nlm.nih.gov/pubmed/33073016 http://dx.doi.org/10.3390/ijns6010019

Ejemplares similares

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
por: Johnson, Faye, et al.
Publicado: (2019)

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
por: Sinha, Aditi, et al.
Publicado: (2021)

Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome
por: Gunnett, Mohini A., et al.
Publicado: (2023)

Cystic Fibrosis-Screening Positive Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up Permits to Early Identify Patients with CFTR-Related Disorders
por: Castaldo, Alice, et al.
Publicado: (2020)

A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening
por: Tosco, Antonella, et al.
Publicado: (2023)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
por: Chudleigh, Jane, et al.
Publicado: (2022)

Pseudo‐Bartter syndrome in infant with cystic fibrosis screen positive, inconclusive diagnosis: A case report
por: Sepe, Angela, et al.
Publicado: (2023)

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process
por: Munck, Anne, et al.
Publicado: (2017)

Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience
por: Bianchimani, Chiara, et al.
Publicado: (2022)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
por: Tridello, Gloria, et al.
Publicado: (2018)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
por: Sherman, Victoria, et al.
Publicado: (2020)

Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening
por: Patterson, K. D., et al.
Publicado: (2019)

Newborn Screening for Cystic Fibrosis: Over the Hump, Still Need to Fine-Tune It
por: Castellani, Carlo
Publicado: (2020)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
por: Botti, Matteo, et al.
Publicado: (2021)

Two Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience
por: Fustik, S, et al.
Publicado: (2021)

Clinical complications in children with false-negative results in cystic fibrosis newborn screening
por: Zybert, Katarzyna, et al.
Publicado: (2021)

Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
por: Grosse, Scott D.
Publicado: (2015)

GMO debate: inconclusive
por: Dronamraju, Krishna
Publicado: (2013)

Anti-Trypanosoma cruzi inconclusive results in blood donor screening
por: Otani, Márcia Mitiko
Publicado: (2012)

Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis
por: Khare, Swapnil, et al.
Publicado: (2021)

Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
por: Thia, Lena P, et al.
Publicado: (2014)

Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening
por: Sicko, Robert J., et al.
Publicado: (2021)

Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis
por: Sandvik, Rikke M., et al.
Publicado: (2023)

Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California
por: Salinas, Danieli B., et al.
Publicado: (2016)

Retraction: GMO debate: inconclusive
Publicado: (2013)

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States
por: Sontag, Marci K., et al.
Publicado: (2022)

Five cases of missed cystic fibrosis heterozygous mutations identified after a positive newborn screen on a sibling
por: Qussous, Khaleel, et al.
Publicado: (2022)

Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion
por: Shenoy, Ambika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v9fgdj82tp47eqrem1omq2l1di